قائمة الدراسات السريرية لتحديد النسل الهرموني
مراجع

1 2 3 4  Rosenfield A (مايو 1982). "The pill: an evaluation of recent studies". Johns Hopkins Med J. ج. 150 ع. 5: 177–80. PMID:7043036.
↑  Grant EC، Robinson J (مايو 1981). "The R.C.G.P. oral contraception study". Lancet. ج. 1 ع. 8231: 1206–7. DOI:10.1016/s0140-6736(81)92366-7. PMID:6112543. S2CID:20271773.
↑  Vessey MP، Lawless M (ديسمبر 1984). "The Oxford-Family Planning Association contraceptive study". Clinics in Obstetrics and Gynaecology. ج. 11 ع. 3: 743–57. DOI:10.1016/S0306-3356(21)00625-7. PMID:6509857.
↑  Ramcharan S، Pellegrin FA، Ray RM، Hsu JP (ديسمبر 1980). "The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives". J Reprod Med. ج. 25 ع. 6 Suppl: 345–72. PMID:7205804.
↑  Savitri Ramcharan، المحرر (1974). Walnut Creek Contraceptive Drug Study: A Prospective Study of the Side Effects of Oral Contraceptives, Volume 3. National Institute of Child Health and Human Development, Center for Population Research. OCLC:1279046. مؤرشف من الأصل في 2022-09-21.
↑  Benagiano, G., & Merialdi, M. (2011). Carl Djerassi and the World Health Organisation special programme of research in human reproduction. Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 8(1), 10-13. http://www.kup.at/kup/pdf/10163.pdf نسخة محفوظة 2023-01-30 على موقع واي باك مشين.
↑  Toppozada MK (أبريل 1994). "Existing once-a-month combined injectable contraceptives". Contraception. ج. 49 ع. 4: 293–301. DOI:10.1016/0010-7824(94)90029-9. PMID:8013216.
↑  Koetsawang S (1991). "The injectable contraceptive: present and future trends". Ann. N. Y. Acad. Sci. ج. 626 ع. 1: 30–42. Bibcode:1991NYASA.626...30K. DOI:10.1111/j.1749-6632.1991.tb37897.x. PMID:1829341. S2CID:27008012.
↑  Oral Contraceptive Hemostasis Study Group (مارس 2003). "The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study". Contraception. ج. 67 ع. 3: 173–85. DOI:10.1016/s0010-7824(02)00476-6. PMID:12618251.
↑  "An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group". Contraception. ج. 59 ع. 6: 345–55. يونيو 1999. DOI:10.1016/s0010-7824(99)00044-x. PMID:10518228.
↑  Hugon-Rodin J، Gompel A، Plu-Bureau G (ديسمبر 2014). "Epidemiology of hormonal contraceptives-related venous thromboembolism". Eur J Endocrinol. ج. 171 ع. 6: R221–30. DOI:10.1530/EJE-14-0527. PMID:25012200.
↑  Dinger J، Do Minh T، Heinemann K (أكتوبر 2016). "Impact of estrogen type on cardiovascular safety of combined oral contraceptives". Contraception. ج. 94 ع. 4: 328–39. DOI:10.1016/j.contraception.2016.06.010. PMID:27343748.
1 2  Morimont L، Haguet H، Dogné JM، Gaspard U، Douxfils J (2021). "Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk". Front Endocrinol (Lausanne). ج. 12: 769187. DOI:10.3389/fendo.2021.769187. PMC:8697849. PMID:34956081.
1 2  Grandi G، Facchinetti F، Bitzer J (فبراير 2022). "Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism". Eur J Contracept Reprod Health Care. ج. 27 ع. 2: 83–84. DOI:10.1080/13625187.2022.2029397. PMID:35133236. S2CID:246651102.
↑  Reed S، Koro C، DiBello J، Becker K، Bauerfeind A، Franke C، Heinemann K (ديسمبر 2021). "Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism". Eur J Contracept Reprod Health Care. ج. 26 ع. 6: 439–446. DOI:10.1080/13625187.2021.1987410. PMID:34644228. S2CID:238858357.
بوابة طب